Search

Soy médico oncólogo certificado por la junta y me especializo en la atención de pacientes con cáncer pulmonar. Soy subdirector del Centro Oncológico de MSK. También soy vicepresidente del Eastern Cooperative Oncology Group Thoracic Committee y soy miembro del National Cancer Institute Thoracic Malignancies Steering Committee.

… Thoracic Medical Oncologist Job Title Subdirector del Centro Oncológico; Codirector, Druckenmiller Center para la Investigación del Cáncer pulmonar; Cátedra de Investigación del Cáncer pulmonar Sylvia Hassenfeld Soy médico oncólogo certificado por la junta y me especializo en la atención de pacientes

Read about the latest findings in immunotherapy from the 2021 annual meeting of the American Society of Clinical Oncology (ASCO).

… Monday, June 7, 2021 Memorial Sloan Kettering researchers presented more than 100 studies at the 2021 American Society of Clinical Oncology (ASCO) annual meeting, held virtually again this year. In case you missed it, here are a few related to immunotherapy that caught our eye. Also from the 2021 ASCO

The information will help you stay safe while you are in the hospital.

MSK doctors perform a variety of tests to diagnose leukemia and determine its type and subtype.

… At Memorial Sloan Kettering we are committed to giving you the most-accurate prognosis and best treatment recommendations possible —whether that means using existing drugs such as chemotherapy or recommending a clinical trial . We routinely test our patients for a large panel of genetic mutations known

Los médicos de MSK realizan una variedad de pruebas para diagnosticar la leucemia y determinar su tipo y subtipo.

… En Memorial Sloan Kettering nos comprometemos a brindarle el pronóstico más preciso y las mejores recomendaciones de tratamiento posibles, ya sea que eso signifique el uso de medicamentos existentes, como la quimioterapia o la recomendación de que participe en un ensayo clínico . De forma regular, evaluamos

The lack of participation in clinical research may be the Achilles’ heel of today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of Memorial Sloan Kettering Cancer Center (MSK), only 35 percent of Americans indicated that they were “likely” to enroll in a clinical trial. Other studies have shown that only 4 percent of cancer patients enroll in clinical trials nationally each year.

… Monday, May 23, 2016 The lack of participation in clinical research may be the Achilles’ heel of today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of Memorial Sloan Kettering Cancer Center (MSK), only 35 percent of Americans

The main treatment for most pituitary tumor patients is a minimally invasive operation called transsphenoidal surgery. Learn more about our expertise.

… VIDEO | 01:36 About Your Transsphenoidal Surgery Learn about transsphenoidal surgery at MSK in this short animation. Video Details The main treatment for most pituitary tumor patients is a minimally invasive operation called transsphenoidal surgery . Memorial Sloan Kettering surgeons are particularly